Plasma concentrations of cyclic 3',5'-guanosine monophosphate in patients with cirrhosis: Relationship with atrial natriuretic peptide and haemodynamics

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 3, 1997, Pages 233-236

  Kirstetter, Philippe ^a   Moreau, Richard ^a   Vachiery, Florence ^a   Gadano, Adrian ^a   Soupison, Thierry ^a   Pilette, Christophe ^a   Pussard, Eric ^b   Cailmail, Stephane ^a   Takahashi, Hakuo ^c   Lebrec, Didier ^a  

^a BEAUJON HOSPITAL   (France)

^b BICÊTRE HOSPITAL   (France)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

cyclic nucleotide; natriuretic peptides; portal hypertension; systemic haemodynamics

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL;

EID: 8244255929     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00414.x     Document Type: Article

References (14)

1. 2 in liver cirrhosis: Relation to blood volume and changes in blood volume after furosemide. Eur. J. Clin. Invest. 1990; 20: 632-41.
2. Vorderwinkler KP, Jakob G, Mair J, Judmaier G, Puschendorf B. Uncoupling of atrial natriuretic peptide and cyclic guanosine 3′,5′-monophosphate production in patients with liver cirrhosis. Clin. Invest. 1994; 72: 138.
3. Chinkers M, Garbers DL, Signal transduction by guanylyl cyclases. Annu. Rev. Biochem. 1991; 60: 553-75.
4. Stasch JP, Kazda S, Neuser D. Different effects of ANP and nitroprusside on cyclic GMP extrusion of isolated aorta. Eur. J. Pharmacol. 1989; 174: 279-82.
5. Moncada S, Palmer RJM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991; 43: 109-42.
6. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophagal varices. Br. J. Surg. 1973; 60: 646-9.
7. Moreau R, Lee SS, Soupison T, Roche-Sicot J, Sicot C. Abnormal tissue oxygenation in patients with cirrhosis and liver failure. J. Hepatol. 1988; 7: 98-105.
8. Takahashi H, Nakanishi T, Nishimura M, Tanaka H, Yoshimura M. Measurements of serum levels of nitrate ions in men and women: Implications of endothelium-derived relaxing factor in blood pressure regulation and atherosclerosis. J. Cardiovasc. Pharmacol. 1992; 20 (Suppl. 12): S214-16.
9. Oshuga M, Moreau R, Hartleb M, Komeichi H, Lebrec D. Blunted systemic, splanchnic, and renal hemodynamic responses to atrial natriuretic peptide in rats with cirrhosis. J. Hepatol. 1994; 20: 91-6.
10. Angeli P, Jimenez W, Arroyo V et al. Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites. Hepatology 1994; 20: 948-54.
11. Lauster F, Heim JM, Drummer C, Fülle HJ, Gerzer R, Schiffl H. Plasma cGMP level as a marker of the hydration state in renal replacement therapy. Kidney Int. 1993; 43 (Suppl. 41): S57-9.
12. Miyase S, Fujiyama S, Chikazawa H, Sato T. Atrial natriuretic peptide in liver cirrhosis with mild ascites. Gastoenterol. Jpn. 1990; 25: 356-62.
13. Schrier RW. Pathogenesis of sodium and water retention in high output and low output cardiac failure, nephrotic syndrome, cirrhosis and pregnancy. N. Engl. J. Med. 1985; 319: 1127-34.
14. Guarner C, Soriano G, Tomas A et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia. Hepatology 1993; 18: 1139-43.